Vanguard Group’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $444M | Buy |
|
|||||
|
2025
Q2 | $390M | Sell |
|
|||||
|
2025
Q1 | $455M | Buy |
|
|||||
|
2024
Q4 | $979M | Buy |
|
|||||
|
2024
Q3 | $1.31B | Buy |
|
|||||
|
2024
Q2 | $740M | Buy |
|
|||||
|
2024
Q1 | $665M | Buy |
|
|||||
|
2023
Q4 | $531M | Buy |
|
|||||
|
2023
Q3 | $422M | Buy |
|
|||||
|
2023
Q2 | $411M | Buy |
|
|||||
|
2023
Q1 | $245M | Sell |
|
|||||
|
2022
Q4 | $317M | Buy |
|
|||||
|
2022
Q3 | $107M | Buy |
|
|||||
|
2022
Q2 | $86.1M | Buy |
|
|||||
|
2022
Q1 | $87.6M | Buy |
|
|||||
|
2021
Q4 | $74.6M | Buy |
|
|||||
|
2021
Q3 | $77.2M | Buy |
|
|||||
|
2021
Q2 | $64.1M | Buy |
|
|||||
|
2021
Q1 | $54.7M | Buy |
|
|||||
|
2020
Q4 | $38.5M | Buy |
|
|||||
|
2020
Q3 | $66.8M | Buy |
|
|||||
|
2020
Q2 | $948K | Buy |
|